We have located links that may give you full text access.
Early and long-term outcomes following redo mitral valve surgery in patients with prior minimally invasive mitral valve surgery.
Interdiscip Cardiovasc Thorac Surg 2024 March 19
OBJECTIVES: The frequency of minimally invasive mitral valve surgery has steadily increased over the last decades and therefore surgeons are now encountering an increasing number of patients requiring mitral valve reoperations post-minimally invasive mitral valve surgery. The aim of this study was to analyze the early postoperative outcomes and the long-term survival in patients who undergo reoperative mitral valve surgery following previous minimally invasive surgery.
METHODS: Patients who underwent redo mitral valve surgery following prior minimally invasive mitral valve surgery between January 2002 and December 2021 were included in our analysis. Study data were prospectively collected and retrospectively analyzed. The primary outcomes were 30-day mortality and long-term survival.
RESULTS: Among the 187 included patients, 34 (18.2%) underwent repeat mitral valve repair and 153 (81.8%) mitral valve replacement. Median age was 66 years (Interquartile range 56-74) and 80 (42.8%) patients were female. Redo mitral valve surgery was performed through median sternotomy in 169 patients (90.4%). A total of 77 (41.2%) patients had additional concomitant procedures. Median ICU stay was 1 day (1-5). The 30-day mortality was 6.4% (12/187). Estimated survival at 5 and 12 years was 61.8% and 38.3%, respectively. Preoperative stroke (HR 3.28, 95% CI 1.37-7.85, p = 0.007) as well as infective endocarditis (HR 1.85; 95% CI 1.09-3.11, p = 0.021) were independent predictors of long-term mortality.
CONCLUSIONS: Redo mitral valve surgery following prior minimally invasive mitral valve surgery can be performed safely with low early perioperative mortality and acceptable long-term survival. Preoperative stroke, infective endocarditis and concomitant tricuspid valve surgery are independent predictors of long-term mortality.
METHODS: Patients who underwent redo mitral valve surgery following prior minimally invasive mitral valve surgery between January 2002 and December 2021 were included in our analysis. Study data were prospectively collected and retrospectively analyzed. The primary outcomes were 30-day mortality and long-term survival.
RESULTS: Among the 187 included patients, 34 (18.2%) underwent repeat mitral valve repair and 153 (81.8%) mitral valve replacement. Median age was 66 years (Interquartile range 56-74) and 80 (42.8%) patients were female. Redo mitral valve surgery was performed through median sternotomy in 169 patients (90.4%). A total of 77 (41.2%) patients had additional concomitant procedures. Median ICU stay was 1 day (1-5). The 30-day mortality was 6.4% (12/187). Estimated survival at 5 and 12 years was 61.8% and 38.3%, respectively. Preoperative stroke (HR 3.28, 95% CI 1.37-7.85, p = 0.007) as well as infective endocarditis (HR 1.85; 95% CI 1.09-3.11, p = 0.021) were independent predictors of long-term mortality.
CONCLUSIONS: Redo mitral valve surgery following prior minimally invasive mitral valve surgery can be performed safely with low early perioperative mortality and acceptable long-term survival. Preoperative stroke, infective endocarditis and concomitant tricuspid valve surgery are independent predictors of long-term mortality.
Full text links
Related Resources
Trending Papers
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.International Journal of Molecular Sciences 2024 April 13
Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults.Clinical Infectious Diseases 2024 April 11
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Finerenone: From the Mechanism of Action to Clinical Use in Kidney Disease.Pharmaceuticals 2024 March 27
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app